Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CordenPharma announces a strategic investment of €3.7 million in the manufacturing site infrastructure of its CordenPharma Switzerland facility, located in Liestal, Switzerland.
read more
Endocyte and ITM Isotopen Technologien München announced ITM´s subsidiary Endocyte have signed a long-term global supply agreement for Lutetium-177 EndolucinBeta to support clinical and commercial supply of 177Lu-PSMA-617.
read more
Monday, February 29, 2016
On Wednesday, February 24th, the United States Senate confirmed the nomination of Robert Califf, M.D. to be Commissioner of Food and Drugs. Dr. Califf was sworn into office on February 25th.
read more
Sirnaomics and PNI jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product.
read more
Thursday, December 03, 2020
Reed-Lane has introduced its second Track & Trace-ready cartoning line for unit-level serialization and multi-level aggregation.
read more
PCI Pharma announced that Salim Haffar will join the company as Chief Executive Officer later this year.
read more
Marken announced today the first Marken Global Advisory Board, held on June 19, 2012. As the leader in global life science supply chain management, Marken continues to be the forerunner for promoting industry trends and innovation as well as ...
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more
Thursday, August 10, 2017
Stellar Biotechnologies reported financial results for the three and nine months ended June 30, 2017 and provided an update on its business.
read more
Tuesday, October 10, 2017
ShangPharma and SRI announced a collaboration to accelerate the development of innovative pharmaceuticals targeting neuroinflammation.
read more
The contract provides partial funding for ongoing development of ARX-04, including Phase 3 clinical, manufacturing and regulatory activities.
read more
Rho announced that it has been named the Autoimmune Diseases Statistical and Clinical Coordinating Center (AD-SCCC) for the National Institute of Allergy and Infectious Diseases. As the AD-SCCC, Rho will provide a broad range of services critical for...
read more
LabConnect announced the grand opening of its new facility in Wuxi, China. Together with LabConnect's laboratory capabilities in Australia, the new site strengthens the company's ability to support multi-regional clinical trials while helping Asia-...
read more
Breckenridge announced it has entered into a multi-product agreement with Sam Chun Dang Pharm, under which Breckenridge and SCD expect to develop and commercialize at least seven ANDAs.
read more
WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully.
read more